OpenVSafe by OpenVAERS
Search V-safe

Y75-16239-17236

3 vaccinations 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
921 / CA
Registered
2022-01-07
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-01
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-07
    Registered in v-safe
  5. 2022-01-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  6. 2022-01-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  7. 2022-03-02
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  8. 2022-06-01
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  9. 2022-12-03
    Survey response — 12 months, dose 3
    MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activities
    Free text: Migraines
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech No
22021-01-11Pfizer-BioNTech No
32021-12-01Pfizer-BioNTech No

Free text

Release 12 — 12 months, dose 3

2022-12-03

Symptoms: Migraines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMigraine · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…